Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis?
Authors:
- 25 April 2008
- journal article
- clinical trial
- Published by Springer Nature in Abdominal Radiology
- Vol. 34 (3) , 381-384
Abstract
It is of utmost importance that autoimmune pancreatitis (AIP) be differentiated from pancreatic cancer. Irregular narrowing of the main pancreatic duct is a characteristic finding in AIP; it is useful for differentiating AIP from pancreatic cancer stenosis. This study evaluated the usefulness of magnetic resonance cholangiopancreatography (MRCP) for the diagnosis of AIP and assessed whether MRCP could replace endoscopic retrograde cholangiopancreatography (ERCP) for diagnosing AIP.Keywords
This publication has 10 references indexed in Scilit:
- Clinical diagnostic criteria of autoimmune pancreatitis: revised proposalJournal of Gastroenterology, 2006
- Autoimmune pancreatitis: proposal of IgG4-related sclerosing diseaseJournal of Gastroenterology, 2006
- MRCP of congenital pancreaticobiliary malformationAbdominal Radiology, 2006
- Diagnostic criteria for autoimmune chronic pancreatitis revisitedWorld Journal of Gastroenterology, 2006
- MRCP and MRI findings in 9 patients with autoimmune pancreatitisWorld Journal of Gastroenterology, 2006
- Clinical Difficulties in The Differentiation of Autoimmune Pancreatitis and Pancreatic CarcinomaAmerican Journal of Gastroenterology, 2003
- The double duct sign in patients with malignant and benign pancreatic lesionsGastrointestinal Endoscopy, 2000
- Comparison of Endoscopic Retrograde Cholangiopancreatography with MR Cholangiopancreatography in Patients with PancreatitisRadiology, 1999
- Chronic pancreatitis caused by an autoimmune abnormalityDigestive Diseases and Sciences, 1995
- “Blind” Evaluation of Endoscopic Retrograde Cholangiopancreatography (ERCP) in the Diagnosis of Pancreatic Carcinoma: The “Double Duct” and Other SignsRadiology, 1976